Humacyte (HUMA) News
NASDAQ: HUMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4053-0.0418 (-9.35%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
HUMA news summary
We found 2 recent headlines mentioning Humacyte (HUMA): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. HUMA is making an outsized move today, down 9.35% at $0.4053, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Barclays Initiates Coverage of Humacyte at Equal-Weight", was published by Nasdaq on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Humacyte headlines
- Barclays Initiates Coverage of Humacyte at Equal-WeightFintel reports that on October 7, 2026, Barclays initiated coverage of Humacyte (NASDAQGS:HUMA) with a Equal-Weight recommendation. This initiation follows a prior action on April 8, 2026, when…NasdaqHUMA, BCS
- Weekly Buzz: RARE, REGN Secure FDA Nod, BMRN Stikes Deal; HUMA, EYPT Face Trial Setbacks(RTTNews) - This week's global biopharma roundup captured a mix of regulatory approvals, strategic partnerships, acquisitions, and merger activity, alongside clinical trial breakthroughs and halts.…NasdaqALIT, ARGX, AZN, BMRN